Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: The molecular landscape of lung neuroendocrine tumours (NETs) is still poorly characterised. Lung NETs main prognostic factors currently include stage, histotype, grade, location, and demographic parameters, but molecular biomarkers are still not available, limiting the possibility for personalised therapeutic strategies.
Conference:
Presenting Author:
Authors: Martiradonna M, Pecora G, Mancini C, de Vitis C, Telese S,
Keywords: carcinoid, PBMC, NGS, Whole exome sequencing, WES, FFPE, Lung NET, molecular landscape,
Introduction: Retrospective, single-arm, open-label, case series study evaluating the efficacy of different types of radioligand therapy (RLT): 177Lu, 90Y DOTATATE, or mix of both used in advanced, unresectable progressive rectal NETG1/G2.
Conference:
Presenting Author: Ćwikła J
Authors: Kolasińska-Ćwikla A, Sankowski A, Pałucki J, Sekelcka N, Ćwikła J,
Keywords: Rectal Neuroendocrine Tumour, SST Receptor, Radioligand Therapy (RLT),
Introduction: Serum levels of growth factors associated with endocrine tumours may be potentially useful in detecting their recurrence.
Conference:
Presenting Author: Opalinska M
Authors: Opalinska M, Kurzynska A, Morawiec-Slawek K, Stefanska A, Kolasa M,
Keywords: growth factor, endocrine tumour, TNF-α, Fascin, recurrence risk,
#3843 VIPoma presenting as chronic diarrhea in a 30-year-old Filipino female
Introduction: Pancreatic neuroendocrine tumors are rare neoplasms that arise in the endocrine tissues of the pancreas. They can secrete a variety of peptide hormones including insulin, gastrin, glucagon, and vasoactive intestinal peptide. Secretory tumors such as vasoactive intestinal polypeptides are rare neuroendocrine pancreatic neoplasms characterized by watery diarrhea, hypokalemia, and hypochlorhydria.
Conference:
Presenting Author: Edejer P
Authors: Edejer P, Mendoza R, Pascasio C, Lin T, Cornelio G,
Keywords: Pancreatic NET, Octreotide, DOTATATE, diarrhea,
Introduction: Temozolomide (TMZ) is an alkylating agent and is widely used in the treatment of PanNET. So far, only the MGMT status, defined by its immunohistochemical (IHC) expression or its promoter methylation, has been proposed as predictor of response to TMZ, but its value remains controversial.
Conference:
Presenting Author: Marinoni I
Authors: Cives M, Kirchner P, Palmirotta R, Lauricella E, de Mestier L,
Keywords: PanNET, Temozolomide, MGMT,